Cubist Systematic Strategies, LLC Allogene Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $19.3 Billion
  • Q3 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 102,771 shares of ALLO stock, worth $126,408. This represents 0.0% of its overall portfolio holdings.

Number of Shares
102,771
Holding current value
$126,408
% of portfolio
0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$1.03 - $1.66 $105,854 - $170,599
102,771 New
102,771 $127,000
Q4 2023

Feb 14, 2024
SELL
$2.28 - $3.5 $300,048 - $460,600
-131,600 Reduced 61.45%
82,544 $264,000
Q3 2023

Nov 14, 2023
BUY
$3.17 - $5.96 $615,743 - $1.16 Million
194,241 Added 975.94%
214,144 $678,000
Q2 2023

Aug 14, 2023
SELL
$4.53 - $6.74 $2.05 Million - $3.05 Million
-452,739 Reduced 95.79%
19,903 $98,000
Q1 2023

May 15, 2023
BUY
$4.92 - $8.21 $903,523 - $1.51 Million
183,643 Added 63.54%
472,642 $2.33 Million
Q4 2022

Feb 14, 2023
SELL
$5.62 - $11.11 $1.63 Million - $3.22 Million
-290,246 Reduced 50.11%
288,999 $1.82 Million
Q3 2022

Nov 14, 2022
BUY
$10.32 - $17.28 $3.14 Million - $5.26 Million
304,445 Added 110.79%
579,245 $6.26 Million
Q2 2022

Aug 15, 2022
BUY
$6.78 - $12.28 $466,240 - $844,458
68,767 Added 33.38%
274,800 $3.13 Million
Q1 2022

May 16, 2022
BUY
$7.65 - $15.29 $499,108 - $997,565
65,243 Added 46.34%
206,033 $1.88 Million
Q4 2021

Feb 14, 2022
BUY
$13.13 - $24.52 $1.85 Million - $3.45 Million
140,790 New
140,790 $2.1 Million
Q3 2021

Nov 15, 2021
SELL
$21.01 - $27.64 $2.62 Million - $3.44 Million
-124,598 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$23.49 - $35.8 $2.27 Million - $3.45 Million
96,497 Added 343.39%
124,598 $3.25 Million
Q1 2021

May 17, 2021
SELL
$25.79 - $39.02 $2.17 Million - $3.29 Million
-84,220 Reduced 74.98%
28,101 $992,000
Q4 2020

Feb 16, 2021
BUY
$25.24 - $43.45 $2.83 Million - $4.88 Million
112,321 New
112,321 $2.84 Million
Q3 2020

Nov 16, 2020
SELL
$32.38 - $44.96 $386,714 - $536,957
-11,943 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$18.39 - $54.04 $38,048 - $111,808
-2,069 Reduced 14.77%
11,943 $511,000
Q1 2020

May 15, 2020
SELL
$18.22 - $28.25 $452,238 - $701,193
-24,821 Reduced 63.92%
14,012 $272,000
Q4 2019

Feb 14, 2020
BUY
$24.82 - $31.4 $963,835 - $1.22 Million
38,833 New
38,833 $1.01 Million

Others Institutions Holding ALLO

# of Institutions
175
Shares Held
146M
Call Options Held
122K
Put Options Held
36.3K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $177M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email